The effect of probiotic microorganisms and bioactive compounds on chemically induced carcinogenesis in rats

Neoplasma

Volumn 57, Issue 5, 2010, Pages 422-428

  Bertkova, I ^a   Hijova, E ^a   Chmelarova, A ^a   Mojzisova, G ^a   Petrasova, D ^a   Strojny, L ^a   Bomba, A ^a   Zitnan, R ^b  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b RESEARCH INSTITUTE OF ANIMAL PRODUCTION   (Slovakia)

Author keywords

Colon cancer; Flaxseed oil; Horse chestnut; Prebiotics; Probiotics

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BACTERIAL ENZYME; BILE ACID; FRUCTOSE OLIGOSACCHARIDE; HYPPOCASTANI EXTRACTUM SICCUM; INULIN; LINI OLEUM VIRGINALE; PLANT EXTRACT; PREBIOTIC AGENT; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VEGETABLE OIL; CYTOKINE; LINSEED OIL;

ARTICLE; BIOCHEMISTRY; CARCINOGENESIS; COLIFORM BACTERIUM; COLON CANCER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; IMMUNOLOGICAL PARAMETERS; LACTOBACILLUS PLANTARUM; LIPID DIET; MALE; MICROORGANISM; NONHUMAN; RAT; WISTAR ALBINO GLAXO RAT; AESCULUS HIPPOCASTANUM; ANIMAL; BACTERIAL LOAD; BLOOD; CHEMICALLY INDUCED DISORDER; COLON TUMOR; HUMAN; IMMUNOLOGY; LACTOBACILLUS; METABOLISM; TUMOR CELL LINE; WEIGHT GAIN; WISTAR RAT;

1,2-DIMETHYLHYDRAZINE; AESCULUS; ANIMALS; BACTERIAL LOAD; BILE ACIDS AND SALTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOKINES; FEMALE; HUMANS; INULIN; LACTOBACILLUS; LINSEED OIL; MALE; PLANT EXTRACTS; PROBIOTICS; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 79952109296     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_05_422     Document Type: Article

References (36)

1. DAUCHET L, AMOUYEL P, HERCBERG S, DALLONGEVILLE J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 2006; 136: 2588-2593.
2. WHO/FAO. Diet, nutrition and the prevention of chronic diseases: report of a Joint FAO/WHO consultation, Geneva, 28 January-1 February 2002. WHO: Geneva.
3. WOLLOWSKI I, RECHKEMMER G, POOL-ZOBEL BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 2001; 73: 451-455.
4. PIERRE F, PERRIN P, CHAMP M, BORNET F, MEFLAH K et al. Short-chain Fructo-oligosaccharides reduce the occurrence of colon tumours and develop gut-associated lymphoid tissue in Min mice. Cancer Res 1997; 57: 224-228.
5. ROBERFROID MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 2000; 71: 1682-1687.
6. BOMMAREDDY A, ARASADA BL, MATHEES DP, DWIVEDI C. Chemopreventive effects of dietary flaxseed on colon tumour development. Nutr Cancer 2006; 54: 216-222. doi:10.1207/s15327914nc5402_8
7. VAN LOO J. The specificity of the interaction with intestinal fermentation by prebiotics determines their physiological efficiacy. Nutr Res Rev 2004; 17: 89-98. doi:10.1079/NRR200377
8. PARKIN DM, BRAY F, FERLAY J, PISANI P. Global cancer statistics 2002. CA Cancer J Clin 2005, 55, 74-108. doi:10.3322/canjclin.55.2.74
9. LIONG MT. Roles of Probiotics and Prebiotics in Colon Cancer Prevention: Postulated Mechenisms and In-vivo Evidence. Int J Mol Sci 2008; 9: 854-863. doi:10.3390/ijms9050854 2635701
10. RAFTER J. The effect of probiotics on colon cancer development. Nutr Res Rev 2004; 17: 277-284. doi:10.1079/ NRR200484
11. FULLER R. The effect of probiotics on the gut microbiology of farm animals. Wood BJB: The Lactic Acid Bacteria, London: Elsevier Applied Science 1992: 171-192.
12. SAGGIORO A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004; 38 (6 Suppl): 104-106. doi:10.1097/01.mcg.0000129271.98814.e2
13. SAAVEDRA M. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr Clin Pract 2007; 22: 351-365. doi:10.1177/0115426507022003351
14. MEURMAN JH, STAMATOVA I. Probiotics: contributions to oral health. Oral Dis Sep 2007; 13: 443-451. doi:10.1111/ j.1601-0825.2007.01386.x
15. LIONG MT. Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments. Nutr Rev 2007; 65: 316-328. doi:10.1111/j.1753-4887.2007.tb00309.x
16. BONGAERTS G, SEVERIJNEN R, TIMMERMAN H. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy. Med Hypotheses 2005; 64: 64-68. doi:10.1016/j.mehy.2004.07.029
17. ALI AA, VELASQEZ MT, HANSEN CT, MOHAMED AI, BHATHENA SH. Modulation of carbohydrate metabolism and peptide hormones by soybean isoflavones and probiotics in obesity and diabetes J Nutr Biochem 2005; 16: 693-699. doi:10.1016/j.jnutbio.2005.03.011
18. ROWLAND IR, BEARNE CA, FISCHER R, POOL-ZOBEL BL. The effect of lactulose on DNA damage induced by 1,2-dimetylhydrazine in the colon of human flora-associated rats. Nutr Cancer 1996; 26: 37-47. doi:10.1080/01635589609514461
19. REDDY BS, HAMID R, RAO CV. Effect of dietary oligofructose and inulin on colonic preneoplastic abberant crypty foci inhibition. Carcinogenesis 1997; 18: 1371-1374. doi:10.1093/ carcin/18.7.1371
20. RAITANO A, KORC M. Growth inhibition of a human colorectal carcinoma cell line by interleukin-1 as associated with enhanced expression of γ-interferon receptors. Cancel Res 1993; 53: 636-640.
21. SIVIERI K, SPINARDI-BARBISAN ALT, BARBISAN LF, BEDANI R, PAULY ND et al. Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male Wistar rats. European Food Research and Technology 2008; 2: 231-237. doi:10.1007/s00217-008-0927-6
22. SEKINE K, KAWASHIMA T, HASHIMOTO Y. Comparison of the TNF-α levels induced by human-derived Bifidobacterium longum and rat-derived Bifidobacterium animalis in mouse peritoneal cells. Bifidobacteria Microflora 1994; 13, 79-89.
23. KAMINSKA J, KOWALSKA MM, NOWACKI MP, CHWALINSKI MG, RYSINSKA A et al. CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients. Pathol Oncol Res 2000; 6: 38-41. doi:10.1007/BF03032656
24. KINOSHITA T, ITO H, MIKI C. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer 1999; 85: 2526-2531. doi:10.1002/(SICI)1097-0142(19990615)85:12<2526::AIDCNCR6> 3.0.CO;2-3
25. FEMIA AP, LUCERI C, DOLARA P, GIANNINI A, BIGGERI A et al. Antitumorigenic activity of the prebiotic inuline enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002; 23: 1953-1960. doi:10.1093/carcin/ 23.11.1953
26. POOL-ZOBEL BL. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr 2005; Suppl 1: 73-90.
27. GALLAHER DD, KHIL J. The effect of synbiotics on colon carcinogenesis in rats. J Nutr 1999; 129: 1483-1487.
28. DWIVEDI C, NATARAJAN K, MATTHEES DP. Chemopreventive effects of dietary flaxeed oil on colon tumor development. Nutr Cancer 2005; 51: 52-58. doi:10.1207/ s15327914nc5101_8
29. GEBAUER SK, PSOTA TL, HARRIS WS, KRIS-ETHERTON PM. n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006; 83 (suppl): 1526-1535.
30. BOMMAREDDY A, ZHANG X, SCHRADER D, KAUSHIK RS, ZEMAN D et al. Effect of dietary flaxeed on intestinal tumorigenesis in Apc(Min) mouse. Nutr Cancer 2009; 61: 276-283. doi:10.1080/01635580802419764
31. JEMAL A, MURRAY T, WARD E, SAMUELS A, TIWARI RC et al. Cancer Statistics, 2005. CA Cancer J Clin 2005; 53: 10-30. doi:10.3322/canjclin.55.1.10
32. BIELANSKI TE, PIOTROWSKI ZH. Horse-chestnut seed extract for chronic venous insufficiency. J Fam Pract 1999; 48: 171-172.
33. SIRTORI CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res 2001; 44: 183-193. doi:10.1006/phrs.2001.0847
34. PATLOLLA MR, RAJU J, SWAMY MV, RAO CV. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by including p21(waf1/cip1) in colon cancer cells. Mol Cancer Ther 2006; 5: 1459-1466. doi:10.1158/1535-7163.MCT-05-0495
35. DEBRUYNE PR, BRUYNEEL EA, KARAGUNI IM, LI XD, FLATAU G et al. Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene 2002; 21: 6740-6750. doi:10.1038/sj.onc.1205729
36. HAGIWARA T. Bile acids and colorectal cancer. Jpn J Cancer Clinics 2006; 51: 919-925.